Tumor suppressor in lung cancer-1 (TSLC1) mediated by dual-regulated oncolytic adenovirus exerts specific antitumor actions in a mouse model
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor suppressor in lung cancer-1 (TSLC1) mediated by dual-regulated oncolytic adenovirus exerts specific antitumor actions in a mouse model
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume 34, Issue 4, Pages 531-540
Publisher
Springer Nature
Online
2013-03-18
DOI
10.1038/aps.2012.196
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Androgen pathway stimulates MicroRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis
- (2012) Po-Jen Chen et al. HEPATOLOGY
- Overexpression of tumor suppressor TSLC1 by a survivin-regulated oncolytic adenovirus significantly inhibits hepatocellular carcinoma growth
- (2012) Guoqing He et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Increased tumorigenesis associated with loss of the tumor suppressor gene Cadm1
- (2012) Louise van der Weyden et al. Molecular Cancer
- Prostate Cancer-Specific and Potent Antitumor Effect of a DD3-Controlled Oncolytic Virus Harboring the PTEN Gene
- (2012) Miao Ding et al. PLoS One
- MicroRNA-10b promotes migration and invasion through CADM1 in human hepatocellular carcinoma cells
- (2012) Qing-jun Li et al. TUMOR BIOLOGY
- Trichosanthin enhances anti-tumor immune response in a murine Lewis lung cancer model by boosting the interaction between TSLC1 and CRTAM
- (2011) Yuchan Cai et al. Cellular & Molecular Immunology
- Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene
- (2011) X Cao et al. GENE THERAPY
- Augmenting the Antitumor Effect of TRAIL by SOCS3 with Double-Regulated Replicating Oncolytic Adenovirus in Hepatocellular Carcinoma
- (2011) Rui-Cheng Wei et al. HUMAN GENE THERAPY
- A Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma
- (2011) Tae-Ho Hwang et al. MOLECULAR THERAPY
- Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
- (2011) Caroline J. Breitbach et al. NATURE
- Epigenetic Silencing of IRF7 and/or IRF5 in Lung Cancer Cells Leads to Increased Sensitivity to Oncolytic Viruses
- (2011) Qunfang Li et al. PLoS One
- Tumor suppressor CADM1 is involved in epithelial cell structure
- (2009) Mika Sakurai-Yageta et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Potent antitumor activity of double-regulated oncolytic adenovirus-mediated ST13 for colorectal cancer
- (2009) De Bin Yu et al. CANCER SCIENCE
- Potent Antitumor Effect of Interleukin-24 Gene in the Survivin Promoter and Retinoblastoma Double-Regulated Oncolytic Adenovirus
- (2009) Kang Jian Zhang et al. HUMAN GENE THERAPY
- Gene-Viral Cancer Therapy Using Dual-Regulated Oncolytic Adenovirus with Antiangiogenesis Gene for Increased Efficacy
- (2008) C. Su et al. MOLECULAR CANCER RESEARCH
- New wirings in the survivin networks
- (2008) D C Altieri ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search